Prevention Of Peritoneal Dialysis-Related Infections

Seminars in Nephrology

Volumn 31, Issue 2, 2011, Pages 199-212

  Nessim, Sharon J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Catheter infection; Peritoneal dialysis; Peritonitis; Prevention; Prophylaxis

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFUROXIME; DIALYSIS FLUID; FLUCONAZOLE; GENTAMICIN; NYSTATIN; PLACEBO; POLYSPORIN; PSEUDOMONIC ACID; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CATHETER INFECTION; CATHETERIZATION; CHEMOPROPHYLAXIS; DIALYSIS CATHETER; DRUG USE; HUMAN; INFECTION COMPLICATION; INFECTION RISK; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT EDUCATION; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK REDUCTION;

ANTI-BACTERIAL AGENTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION; CATHETERS, INDWELLING; HUMANS; PATIENT EDUCATION AS TOPIC; PERITONEAL DIALYSIS; PERITONITIS;

EID: 79952783183     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2011.01.008     Document Type: Article

References (110)

1. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006, 103:S55-S62.
2. Kavanagh D., Prescott G.J., Mactier R.A. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 2004, 19:2584-2591.
3. Luzar M.A., Coles G.A., Faller B., Slingeneyer A., Dah G.D., Briat C., et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990, 322:505-509.
4. Yip T., Tse K.C., Lam M.F., Cheng S.W., Lui S.L., Tang S., et al. Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int 2007, 27:560-564.
5. Bac D.J., van Blankenstein M., de Marie S., Fieren M.W. Peritonitis following endoscopic polypectomy in a peritoneal dialysis patient: the need for antibiotic prophylaxis. Infection 1994, 22:220-221.
6. Ray S.M., Piraino B., Holley J. Peritonitis following colonoscopy in a peritoneal dialysis patient. Perit Dial Int 1990, 10:97-98.
7. Petersen J.H., Weesner R.E., Giannella R.A. Escherichia coli peritonitis after left-sided colonoscopy in a patient on continuous ambulatory peritoneal dialysis. Am J Gastroenterol 1987, 82:171-172.
8. Verger C., Danne O., Vuillemin F. Colonoscopy and continuous ambulatory peritoneal dialysis. Gastrointest Endosc 1987, 33:334-335.
9. Chuang Y.W., Shu K.H., Yu T.M., Cheng C.H., Chen C.H. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 2009, 24:1603-1608.
10. Yip T., Tse K.C., Lam M.F., Cheng S.W., Lui S.L., Tang S., et al. Colonic diverticulosis as a risk factor for peritonitis in Chinese peritoneal dialysis patients. Perit Dial Int 2010, 30:187-191.
11. Tranaeus A., Heimburger O., Granqvist S. Diverticular disease of the colon: a risk factor for peritonitis in continuous peritoneal dialysis. Nephrol Dial Transplant 1990, 5:141-147.
12. Singharetnam W., Holley J.L. Acute treatment of constipation may lead to transmural migration of bacteria resulting in gram-negative, polymicrobial, or fungal peritonitis. Perit Dial Int 1996, 16:423-425.
13. Caravaca F., Ruiz-Calero R., Dominguez C. Risk factors for developing peritonitis caused by micro-organisms of enteral origin in peritoneal dialysis patients. Perit Dial Int 1998, 18:41-45.
14. Nessim S.J., Tomlinson G., Bargman J.M., Jassal S.V. Gastric acid suppression and the risk of enteric peritonitis in peritoneal dialysis patients. Perit Dial Int 2008, 28:246-251. discussion 36-7.
15. Fried L., Bernardini J., Piraino B. Iatrogenic peritonitis: the need for prophylaxis. Perit Dial Int 2000, 20:343-345.
16. Shavit L., Lifschitz M., Plaksin J., Grenader T., Slotki I. Postcoital peritonitis associated with transvaginal leak of dialysate in a CAPD patient. Perit Dial Int 2006, 26:720-722.
17. Yap D.Y., Tse K.C., Lam M.F., Chan T.M., Lai K.N. Polymicrobial CAPD peritonitis after hysteroscopy. Perit Dial Int 2009, 29:237-238.
18. Golper T.A., Brier M.E., Bunke M., Schreiber M.J., Bartlett D.K., Hamilton R.W., et al. Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Dis 1996, 28:428-436.
19. Piraino B., Bernardini J., Florio T., Fried L. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int 2003, 23:456-459.
20. Piraino B., Bailie G.R., Bernardini J., Boeschoten E., Gupta A., Holmes C., et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005, 25:107-131.
21. Li P.K., Szeto C.C., Piraino B., Bernardini J., Figueiredo A.E., Gupta A., et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010, 30:393-423.
22. Bernardini J., Bender F., Florio T., Sloand J., Palmmontalbano L., Fried L., et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005, 16:539-545.
23. Goldie S.J., Kiernan-Tridle L., Torres C., Gorban-Brennan N., Dunne D., Kliger A.S., et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996, 28:86-91.
24. Wang A.Y., Yu A.W., Li P.K., Lam P.K., Leung C.B., Lai K.N., et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000, 36:1183-1192.
25. Prasad K.N., Prasad N., Gupta A., Sharma R.K., Verma A.K., Ayyagari A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect 2004, 48:96-101.
26. Chan T.M., Chan C.Y., Cheng S.W., Lo W.K., Lo C.Y., Cheng I.K. Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients. Nephrol Dial Transplant 1994, 9:539-542.
27. Chang T.I., Kim H.W., Park J.T., Lee D.H., Lee J.H., Yoo T.H., et al. Early catheter removal improves patient survival in peritoneal dialysis patients with fungal peritonitis: results of ninety-four episodes of fungal peritonitis at a single center. Perit Dial Int 2010, Epub ahead of print.
28. Gupta B., Bernardini J., Piraino B. Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis 1996, 28:415-419.
29. Bernardini J., Piraino B., Sorkin M. Analysis of continuous ambulatory peritoneal dialysis-related Pseudomonas aeruginosa infections. Am J Med 1987, 83:829-832.
30. Bunke M., Brier M.E., Golper T.A. Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study. Am J Kidney Dis 1995, 25:769-774.
31. Szeto C.C., Chow K.M., Leung C.B., Wong T.Y., Wu A.K., Wang A.Y., et al. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases. Kidney Int 2001, 59:2309-2315.
32. Barraclough K., Hawley C.M., McDonald S.P., Brown F.G., Rosman J.B., Wiggins K.J., et al. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis 2010, 55:121-131.
33. Bennett-Jones D., Martin J., Barrat A.J., et al. Prophylactic gentamicin in the prevention of early exit-site infections and peritonitis in CAPD. Adv Perit Dial 1988, 4:147-150.
34. Sardegna K.M., Beck A.M., Strife C.F. Evaluation of perioperative antibiotics at the time of dialysis catheter placement. Pediatr Nephrol 1998, 12:149-152.
35. Lye W.C., Lee E.J., Tan C.C. Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand J Urol Nephrol 1992, 26:177-180.
36. Gadallah M.F., Ramdeen G., Mignone J., Patel D., Mitchell L., Tatro S. Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters. Am J Kidney Dis 2000, 36:1014-1019.
37. Wikdahl A.M., Engman U., Stegmayr B.G., Sorenssen J.G. One-dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion. Nephrol Dial Transplant 1997, 12:157-160.
38. Classen D.C., Evans R.S., Pestotnik S.L., Horn S.D., Menlove R.L., Burke J.P. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992, 326:281-286.
39. Akyol A.M., Porteous C., Brown M.W. A comparison of two types of catheters for continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1990, 10:63-66.
40. Scott P.D., Bakran A., Pearson R., Riad H., Parrott N., Johnson R.W., et al. Peritoneal dialysis access. Prospective randomized trial of 3 different peritoneal catheters-preliminary report. Perit Dial Int 1994, 14:289-290.
41. Eklund B.H., Honkanen E.O., Kala A.R., Kyllonen L.E. Catheter configuration and outcome in patients on continuous ambulatory peritoneal dialysis: a prospective comparison of two catheters. Perit Dial Int 1994, 14:70-74.
42. Eklund B.H., Honkanen E.O., Kala A.R., Kyllonen L.E. Peritoneal dialysis access: prospective randomized comparison of the Swan neck and Tenckhoff catheters. Perit Dial Int 1995, 15:353-356.
43. Nielsen P.K., Hemmingsen C., Friis S.U., Ladefoged J., Olgaard K. Comparison of straight and curled Tenckhoff peritoneal dialysis catheters implanted by percutaneous technique: a prospective randomized study. Perit Dial Int 1995, 15:18-21.
44. Lye W.C., Kour N.W., van der Straaten J.C., Leong S.O., Lee E.J. A prospective randomized comparison of the Swan neck, coiled, and straight Tenckhoff catheters in patients on CAPD. Perit Dial Int 1996, 16(Suppl 1):S333-S335.
45. Strippoli G.F., Tong A., Johnson D., Schena F.P., Craig J.C. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol 2004, 15:2735-2746.
46. Warady B.A., Sullivan E.K., Alexander S.R. Lessons from the peritoneal dialysis patient database: a report of the North American Pediatric Renal Transplant Cooperative Study. Kidney Int Suppl 1996, 53:S68-S71.
47. Honda M., Iitaka K., Kawaguchi H., Hoshii S., Akashi S., Kohsaka T., et al. The Japanese National Registry data on pediatric CAPD patients: a ten-year experience. A report of the Study Group of Pediatric PD Conference. Perit Dial Int 1996, 16:269-275.
48. Eklund B., Honkanen E., Kyllonen L., Salmela K., Kala A.R. Peritoneal dialysis access: prospective randomized comparison of single-cuff and double-cuff straight Tenckhoff catheters. Nephrol Dial Transplant 1997, 12:2664-2666.
49. Catheter-related factors and peritonitis risk in CAPD patients. Am J Kidney Dis 1992, 20(Suppl 2):48-54.
50. Nessim S.J., Bargman J.M., Jassal S.V. Relationship between double-cuff versus single-cuff peritoneal dialysis catheters and risk of peritonitis. Nephrol Dial Transplant 2010, 25:2310-2314.
51. Danielsson A., Blohme L., Tranaeus A., Hylander B. A prospective randomized study of the effect of a subcutaneously "buried" peritoneal dialysis catheter technique versus standard technique on the incidence of peritonitis and exit-site infection. Perit Dial Int 2002, 22:211-219.
52. Wu C.C., Su P.F., Chiang S.S. A prospective study to compare subcutaneously buried peritoneal dialysis catheter technique with conventional technique. Blood Purif 2007, 25:229-232.
53. Miller T.E., Findon G. Touch contamination of connection devices in peritoneal dialysis-a quantitative microbiologic analysis. Perit Dial Int 1997, 17:560-567.
54. Bordin G., Casati M., Sicolo N., Zuccherato N., Eduati V. Patient education in peritoneal dialysis: an observational study in Italy. J Ren Care 2007, 33:165-171.
55. Hall G., Bogan A., Dreis S., Duffy A., Greene S., Kelley K., et al. New directions in peritoneal dialysis patient training. Nephrol Nurs J 2004, 31:149-154. 59-63.
56. Bernardini J., Price V., Figueiredo A. Peritoneal dialysis patient training, 2006. Perit Dial Int 2006, 26:625-632.
57. Chen T.W., Li S.Y., Chen J.Y., Yang W.C. Training of peritoneal dialysis patients-Taiwan's experiences. Perit Dial Int 2008, 28(Suppl 3):S72-S75.
58. Chow K.M., Szeto C.C., Law M.C., Fun Fung J.S., Kam-Tao Li P. Influence of peritoneal dialysis training nurses' experience on peritonitis rates. Clin J Am Soc Nephrol 2007, 2:647-652.
59. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Canadian CAPD Clinical Trials Group. Perit Dial Int 1989, 9:159-163.
60. Maiorca R., Cantaluppi A., Cancarini G.C., Scalamogna A., Broccoli R., Graziani G., et al. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1983, 2:642-644.
61. Lindholm T., Simonsen O., Krutzen R., et al. Evaluation of a new take-off system: a prospective randomized multicenter study. Adv Perit Dial 1988, 4:264-265.
62. Monteon F., Correa-Rotter R., Paniagua R., Amato D., Hurtado M.E., Medina J.L., et al. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology Collaborative Study Group. Kidney Int 1998, 54:2123-2128.
63. Kiernan L., Kliger A., Gorban-Brennan N., Juergensen P., Tesin D., Vonesh E., et al. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems. J Am Soc Nephrol 1995, 5:1835-1838.
64. Harris D.C., Yuill E.J., Byth K., Chapman J.R., Hunt C. Twin- versus single-bag disconnect systems: infection rates and cost of continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996, 7:2392-2398.
65. Li P.K., Szeto C.C., Law M.C., Chau K.F., Fung K.S., Leung C.B., et al. Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study. Am J Kidney Dis 1999, 33:535-540.
66. Sewell C.M., Clarridge J., Lacke C., Weinman E.J., Young E.J. Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients. JAMA 1982, 248:1493-1495.
67. Davies S.J., Ogg C.S., Cameron J.S., Poston S., Noble W.C. Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989, 9:61-64.
68. Zimmerman S.W., Ahrens E., Johnson C.A., Craig W., Leggett J., O'Brien M., et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 1991, 18:225-231.
69. Bernardini J., Piraino B., Holley J., Johnston J.R., Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996, 27:695-700.
70. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol 1996, 7:2403-2408.
71. Perez-Fontan M., Garcia-Falcon T., Rosales M., Rodriguez-Carmona A., Adeva M., Rodriguez-Lozano I., et al. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results. Am J Kidney Dis 1993, 22:708-712.
72. Thodis E., Bhaskaran S., Pasadakis P., Bargman J.M., Vas S.I., Oreopoulos D.G. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998, 18:261-270.
73. Casey M., Taylor J., Clinard P., Graham A., Mauck V., Spainhour L., et al. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients. Perit Dial Int 2000, 20:566-568.
74. Mahajan S., Tiwari S.C., Kalra V., Bhowmik D.M., Agarwal S.K., Dash S.C., et al. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population. Perit Dial Int 2005, 25:473-477.
75. Uttley L., Vardhan A., Mahajan S., Smart B., Hutchison A., Gokal R. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site. J Nephrol 2004, 17:242-245.
76. Zeybel M., Ozder A., Sanlidag C., Yildiz S., Cavdar C., Ersoy R., et al. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2003, 19:198-201.
77. Wong S.S., Chu K.H., Cheuk A., Tsang W.K., Fung S.K., Chan H.W., et al. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site. Perit Dial Int 2003, 23(Suppl 2):S153-S158.
78. Lim C.T., Wong K.S., Foo M.W. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital. Nephrol Dial Transplant 2005, 20:1702-1706.
79. Crabtree J.H., Hadnott L.L., Burchette R.J., Siddiqi R.A. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Adv Perit Dial 2000, 16:271-275.
80. Chu K.H., Choy W.Y., Cheung C.C., Fung K.S., Tang H.L., Lee W., et al. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections. Perit Dial Int 2008, 28:505-508.
81. Mahaldar A., Weisz M., Kathuria P. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis. Adv Perit Dial 2009, 25:56-59.
82. Jassal S.V., Lok C.E. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study). Perit Dial Int 2008, 28:67-72.
83. Johnson D.W., Clark C., Isbel N.M., Hawley C.M., Beller E., Cass A., et al. The honeypot study protocol: a randomized controlled trial of exit-site application of Medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Perit Dial Int 2009, 29:303-309.
84. Johnson D.W., van Eps C., Mudge D.W., Wiggins K.J., Armstrong K., Hawley C.M., et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 2005, 16:1456-1462.
85. Vas S.I., Conly J., Bargman J.M., Oreopoulos D.G. Resistance to mupirocin: no indication of it to date while using mupirocin ointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients. Perit Dial Int 1999, 19:313-314.
86. Perez-Fontan M., Rosales M., Rodriguez-Carmona A., Falcon T.G., Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002, 39:337-341.
87. Lobbedez T., Gardam M., Dedier H., Burdzy D., Chu M., Izatt S., et al. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant 2004, 19:3140-3143.
88. Annigeri R., Conly J., Vas S., Dedier H., Prakashan K.P., Bargman J.M., et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001, 21:554-559.
89. Bordes A., Campos-Herrero M.I., Fernandez A., Vega N., Rodriguez J.C., Palop L. Predisposing and prognostic factors of fungal peritonitis in peritoneal dialysis. Perit Dial Int 1995, 15:275-276.
90. Miles R., Hawley C.M., McDonald S.P., Brown F.G., Rosman J.B., Wiggins K.J., et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009, 76:622-628.
91. Warady B.A., Bashir M., Donaldson L.A. Fungal peritonitis in children receiving peritoneal dialysis: a report of the NAPRTCS. Kidney Int 2000, 58:384-389.
92. Lo W.K., Chan C.Y., Cheng S.W., Poon J.F., Chan D.T., Cheng I.K. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996, 28:549-552.
93. Restrepo C., Chacon J., Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int 2010, 30:619-625.
94. Zaruba K., Peters J., Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. Am J Kidney Dis 1991, 17:43-46.
95. Robitaille P., Merouani A., Clermont M.J., Hebert E. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int 1995, 15:77-79.
96. Wadhwa N.K., Suh H., Cabralda T. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. Adv Perit Dial 1996, 12:189-191.
97. Wong P.N., Lo K.Y., Tong G.M., Chan S.F., Lo M.W., Mak S.K., et al. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int 2007, 27:531-536.
98. Thodis E., Vas S.I., Bargman J.M., Singhal M., Chu M., Oreopoulos D.G. Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1998, 18:583-589.
99. Williams P.F., Moncrieff N., Marriott J. No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2000, 20:352-353.
100. Mortier S., De Vriese A.S., McLoughlin R.M., Topley N., Schaub T.P., Passlick-Deetjen J., et al. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. J Am Soc Nephrol 2003, 14:1296-1306.
101. Liberek T., Topley N., Jorres A., Coles G.A., Gahl G.M., Williams J.D. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. J Am Soc Nephrol 1993, 3:1508-1515.
102. Fusshoeller A., Plail M., Grabensee B., Plum J. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Nephrol Dial Transplant 2004, 19:2101-2106.
103. Pajek J., Kveder R., Bren A., Gucek A., Ihan A., Osredkar J., et al. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. Perit Dial Int 2008, 28:44-52.
104. Lee H.Y., Park H.C., Seo B.J., Do J.Y., Yun S.R., Song H.Y., et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int 2005, 25:248-255.
105. Lee H.Y., Choi H.Y., Park H.C., Seo B.J., Do J.Y., Yun S.R., et al. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant 2006, 21:2893-2899.
106. Furkert J., Zeier M., Schwenger V. Effects of peritoneal dialysis solutions low in GDPs on peritonitis and exit-site infection rates. Perit Dial Int 2008, 28:637-640.
107. Montenegro J., Saracho R., Gallardo I., Martinez I., Munoz R., Quintanilla N. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Nephrol Dial Transplant 2007, 22:1703-1708.
108. Ahmad S., Sehmi J.S., Ahmad-Zakhi K.H., Clemenger M., Levy J.B., Brown E.A. Impact of new dialysis solutions on peritonitis rates. Kidney Int Suppl 2006, 103:S63-S66.
109. Fan S.L., Pile T., Punzalan S., Raftery M.J., Yaqoob M.M. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int 2008, 73:200-206.
110. Haag-Weber M., Kramer R., Haake R., Islam M.S., Prischl F., Haug U., et al. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. Nephrol Dial Transplant 2010, 25:2288-2296.